Detection of rearrangements in the NF2 gene using semi-quantitative multiplex fluorescent PCR

Genetic Testing

Volumn 9, Issue 1, 2005, Pages 14-19

  Sestini, Roberta ^a   Putignano, Anna Laura ^a   Ammannati, Franco ^b   Papi, Laura ^a,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c Dipartimento di Fisiopatologia Clinica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; MONOSOMY; NEUROFIBROMATOSIS; NEUROFIBROMATOSIS 2 GENE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; QUANTITATIVE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; TRISOMY;

BASE SEQUENCE; DNA PRIMERS; FLUORESCENCE; GENE REARRANGEMENT; GENES, NEUROFIBROMATOSIS 2; HUMANS; POLYMERASE CHAIN REACTION;

EID: 17844400582     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2005.9.14     Document Type: Article

References (21)

1. BASER, M.E., FRIEDMAN, J.M., AESCHLIMAN, D., et al. (2002). Predictors of the risk of mortality in neurofibromatosis 2. Am. J. Hum. Genet. 71, 715-723.
2. BRUDER, C.E., HIRVELA, C., TAPIA-PAEZ, I., FRANSSON, I., et al. (2001). High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum. Mol. Genet. 10, 271-282.
3. CHARBONNIER, F., RAUX, G., WANG, Q., et al. (2000). Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res. 60, 2760-2763.
4. DE VITIS, L.R., TEDDE, A., VITELLI, F., et al. (1996). Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. Hum. Genet. 97, 632-637.
5. DUPONCHEL, C., DI ROCCO, C., CICARDI, M., et al. (2001). Rapid detection by fluorescent multiplex PCR of exon deletions and duplications in the Cl inhibitor gene of hereditary angioedema patients. Hum. Mutat. 17, 61-70.
6. EVANS, D.G.R., HUSON, S.M., DONNAI, D., et al. (1992). A genetic study of type 2 Neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness and confirmation of maternal transmission effect on severity. J. Med. Genet. 29, 841-846.
7. EVANS, D.G., TRUEMAN, L., WALLACE, A., et al. (1998). Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J. Med. Genet. 35, 450-455.
8. EVANS, D.G., SAINIO, M., and BASER, M.E. (2000). Neurofibromatosis type 2. J. Med. Genet. 37, 897-904.
9. HOFMANN, W., GORGENS, H., and JOHN, A. (2003). Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method. Hum. Mutat. 22, 103-104.
10. KAISER-KUPFER, M.I., FREIDLIN, V., and DATILES, M.B. (1989). The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch Ophthalmol. 107, 541-544.
11. KLUWE, L., MAUTNER, V., HEINRICH, B., et al. (2003). Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J. Med. Genet. 40, 109-114.
12. LEGOIX, P., LEGRAND, M.F., and OLLAGNON, E. (1999). Characterisation of 16 polymorphic markers in the NF2 gene: application to hemizygosity detection. Hum. Mutat. 13, 290-293.
13. LEGOIX, P., SARKISSIAN, H.D., CAZES, L., et al. (2000). Molecular characterization of germline NF2 gene rearrangements. Genomics 65, 62-6.
14. MOYHUDDIN, A., BASER, M.E., WATSON, C., et al. (2003). Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring. J. Med. Genet. 40, 459-463.
15. PURROY, J., BISCEGLIA, L., JAEKEN, J., et al. (2000). Detection of two novel large deletions in SLC3A1 by semi-quantitative fluorescent multiplex PCR. Hum. Mutat. 15, 373-379.
16. ROULEAU, G.A., MÉREL, P., LUTCHMAN, M., et al. (1993). Alteration in a new gene encoding a putative membrane-organizing protein causes Neurofibromatosis type 2. Nature 363, 515-521.
17. SANSON, M., MARINEAU, C., DESMAZE, C., et al. (1993). Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus. Hum. Mol. Genet. 2, 1215-1220
18. SESTINI, R., VIVARELLI, R., BALESTRI, P., et al. (2000). Neurofibromatosis type 2 attributable to gonosomal mosaicism in a clinically normal mother, and identification of seven novel mutations in the NF2 gene. Hum. Genet. 107, 366-731.
19. TROFATTER, J.A., MACCOLLIN, M.M., RUTTER, J.L., et al. (1993). A novel moesin-, ezrin-, radixin-like gene is a candidate for the Neurofibromatosis 2 tumor suppressor. Cell 72, 791-800.
20. WATSON, C.J., GAUNT, L., EVANS, G., et al. (1993). A disease-associated gerraline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus. Hum. Mol. Genet. 2, 701-704.
21. ZUCMAN-ROSSI, J., LEGOIX, P., DER SARKISSIAN, H., et al. (1998). NF2 gene in neurofibromatosis type 2 patients. Hum. Mol. Genet. 7, 2095-2101.